ALNY
Price
$162.81
Change
+$8.07 (+5.22%)
Updated
Feb 22, 6:59 PM EST
62 days until earnings call
BEAM
Price
$33.54
Change
+$1.78 (+5.60%)
Updated
Feb 22, 6:59 PM EST
4 days until earnings call
Ad is loading...

Compare predictions ALNY vs BEAM

Header iconALNY vs BEAM Comparison
Open Charts ALNY vs BEAMBanner chart's image
Alnylam Pharmaceuticals
Price$162.81
Change+$8.07 (+5.22%)
Volume$552.32K
CapitalizationN/A
Beam Therapeutics
Price$33.54
Change+$1.78 (+5.60%)
Volume$737.6K
CapitalizationN/A
View a ticker or compare two or three
ALNY vs BEAM Comparison Chart

Loading...

ALNYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALNY vs. BEAM commentary
Feb 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and BEAM is a Hold.

COMPARISON
Comparison
Feb 23, 2024
Stock price -- (ALNY: $162.81 vs. BEAM: $33.54)
Brand notoriety: ALNY and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 140% vs. BEAM: 94%
Market capitalization -- ALNY: $20.51B vs. BEAM: $2.73B
ALNY [@Biotechnology] is valued at $20.51B. BEAM’s [@Biotechnology] market capitalization is $2.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $538.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ALNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 7 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • BEAM’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а +10.43% price change this week, while BEAM (@Biotechnology) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.80%. For the same industry, the average monthly price growth was +15.33%, and the average quarterly price growth was +36.95%.

Reported Earning Dates

ALNY is expected to report earnings on Apr 25, 2024.

BEAM is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+1.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALNY with price predictions.
OPEN
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALNY($20.5B) has a higher market cap than BEAM($2.73B). BEAM YTD gains are higher at: 23.218 vs. ALNY (-14.942). ALNY has higher annual earnings (EBITDA): -215.26M vs. BEAM (-379.73M). ALNY has more cash in the bank: 2.44B vs. BEAM (1.02B). BEAM has less debt than ALNY: BEAM (173M) vs ALNY (1.31B). ALNY has higher revenues than BEAM: ALNY (1.83B) vs BEAM (81.6M).
ALNYBEAMALNY / BEAM
Capitalization20.5B2.73B750%
EBITDA-215.26M-379.73M57%
Gain YTD-14.94223.218-64%
P/E RatioN/AN/A-
Revenue1.83B81.6M2,240%
Total Cash2.44B1.02B240%
Total Debt1.31B173M754%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYBEAM
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
69%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ALNYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRGOX72.672.07
+2.93%
T. Rowe Price Lrg Cp Gr Inv
CAEYX25.620.43
+1.71%
Columbia Acorn European Inst3
PAECX17.470.28
+1.63%
Putnam Dynamic Asset Allocation Gr C
DEGCX13.900.17
+1.24%
Delaware International Equity C
MXREX11.73N/A
N/A
Empower Real Estate Index Inv